Search Results

Microbial metabolite 3,4-dihydroxybenzoic acid, derived from dietary fiber, improves acid influences anti-tumor immunity in mice.

Combining chemotherapy with immunotherapy before surgery may shrink head and neck tumors more effectively than immunotherapy alone.

Tool could eventually identify which patients will benefit most from immune checkpoint inhibitors.

UCLA study finds treatment is safe, helps more patients reach surgery and reveals new insights into the tumor’s immune response.

Blood-based testing may help predict immunotherapy response and personalize breast cancer treatment.

Multidisciplinary team at Kilpauk Medical College manages life-threatening thrombotic thrombocytopenic purpura during pregnancy.